From the Taozen blog
·
October 8, 2026
·
5 min read

How long off antidepressants before ayahuasca?

The official drug labels set a gap of 5 days to 5 weeks before an MAO inhibitor. Here are the numbers, where they come from, and what to ask any retreat.

In this article
Key takeaways
  • The official US drug labels set a gap of 5 days to 5 weeks after your last dose before an MAO inhibitor; most say 14 days, and fluoxetine (Prozac) at least 5 weeks.
  • Never stop or cut down a medication on your own. Any taper has to be planned with the prescriber who knows your history.
  • Ask any retreat who reviews your medication list and what washout they require, and why.

There is no single safe number: the official drug labels for common antidepressants set a minimum gap of 5 days to 5 weeks between your last dose and starting an MAO inhibitor (the type of compound in ayahuasca), and most of them say 14 days. Fluoxetine (Prozac) is the outlier, at 5 weeks or more, because it lingers in the body. Do not stop or cut down any medication on your own - talk to the prescriber who knows your history first, because stopping too fast can cause withdrawal symptoms and relapse, and any taper has to be planned and supervised by them.

Here are the numbers, where they come from, and what they can and cannot tell you.

Why does ayahuasca interact with antidepressants at all?

Ayahuasca (yagé) is brewed from the Banisteriopsis caapi vine, which contains the harmala alkaloids harmine and harmaline. These block monoamine oxidase (MAO), the enzyme your body uses to break down serotonin. Callaway and Grob (1998) describe this blockade as lasting "for several hours" after drinking. A 2026 pharmacology study describes harmine as a reversible MAO-A inhibitor (Ribeiro et al., 2026).

Most antidepressants raise serotonin in a different way, by stopping it being taken back up into nerve cells. Put the two together and, in Callaway and Grob's words, you block "two essential pathways for serotonin": the body keeps making it, and can no longer clear it. Too much serotonin can tip into serotonin syndrome.

What is serotonin syndrome, in plain English?

It is a reaction to too much serotonin activity in the body. The FDA-approved label for lithium describes it as "potentially life-threatening" and lists signs including:

  • agitation, confusion, seeing things that are not there, and in severe cases coma
  • fast heartbeat, swings in blood pressure, heavy sweating, flushing, fever
  • tremor, stiff or twitching muscles, loss of coordination, seizures
  • nausea, vomiting, diarrhoea

(Source: Lithium Carbonate prescribing information, section 5.6, via DailyMed.)

Here is the part that matters for ceremony: Callaway and Grob point out that the early signs (euphoria or confusion, vomiting, tremor) overlap with what people commonly experience on a normal dose of ayahuasca. That makes a developing reaction harder to spot in the room. They describe a man taking 20 mg of fluoxetine a day who drank about 100 ml of ayahuasca at a ceremony. Within an hour he had tremors, sweating, shivering and confusion, collapsed outside, and stayed incapacitated with heavy sweating, tremors, nausea and vomiting for several hours. He recovered without treatment after about four hours. The authors are clear that serious cases need fast emergency treatment, and they cite published fatal cases from combining an MAO-A inhibitor with serotonergic antidepressants (Neuvonen et al., 1993, five fatal cases after overdoses of moclobemide plus clomipramine).

How common is it? Honestly, nobody knows. A 2024 systematic review of drug interactions with classic psychedelics found only one ayahuasca study, and says that "except for a few case reports, no serious adverse drug events were described" (Halman et al., 2024). A short list of reported cases does not prove the combination is safe. Controlled studies of this interaction in people have not been done. A 2026 computer-modelling study predicted that fluoxetine and paroxetine increase blood levels of harmine and moderately increase DMT, and its authors call the interaction "clinically relevant" (Ribeiro et al., 2026). That is a simulation, not a human trial.

How long does each type of medication need to clear?

The numbers below come from the official US prescribing information for each drug (FDA labels on DailyMed). They describe the minimum gap after the last dose before starting a pharmaceutical MAO inhibitor antidepressant. No regulator has published a washout figure written specifically for ayahuasca. These label figures are the closest official benchmark, and the people who prescribe your medication will know them.

SSRI: fluoxetine (Prozac): At least 5 weeks. Fluoxetine and its active metabolite norfluoxetine leave the body slowly; the label gives norfluoxetine an elimination half-life of 4 to 16 days. Callaway and Grob (1998) note active metabolites "may remain up to five weeks". Source: Prozac label, sections 2.9 and 4.1; Callaway & Grob 1998

SSRIs: most others (Zoloft (sertraline), Lexapro (escitalopram), Celexa (citalopram), Paxil CR (paroxetine)): At least 14 days. Blocks serotonin reuptake. Combined with an MAO inhibitor, this is the classic serotonin syndrome pairing. Older harm-reduction guidance gave 2 to 3 weeks (Savinelli & Halpern, 1995). Source: Zoloft, Lexapro, Celexa and Paxil CR labels

Other serotonergic antidepressants (Viibryd (vilazodone); Trintellix (vortioxetine)): 14 days (vilazodone); 21 days (vortioxetine). Both act on serotonin. Vortioxetine's gap is longer than most SSRIs. Source: Viibryd label; Trintellix label, section 2.4

SNRIs (Effexor XR (venlafaxine), Pristiq (desvenlafaxine), Fetzima (levomilnacipran), Cymbalta (duloxetine)): At least 7 days (venlafaxine, desvenlafaxine, levomilnacipran); at least 5 days (duloxetine). Raise serotonin and noradrenaline. Shorter label gaps, but the labels still list combining with an MAOI as a contraindication. Source: Effexor XR, Pristiq, Fetzima and Cymbalta labels

Tricyclics (TCAs) (nortriptyline, Anafranil (clomipramine)): At least 14 days. Both labels call combining with an MAOI contraindicated "because of an increased risk of serotonin syndrome". The fatal cases cited by Callaway and Grob involved clomipramine taken in overdose with moclobemide, an MAO-A inhibitor. Source: Nortriptyline and Anafranil labels

MAOI antidepressants (Nardil (phenelzine), Parnate (tranylcypromine), Emsam (selegiline patch)): 14 days between stopping Nardil and starting another MAOI or antidepressant; Parnate's label says MAO inhibition "may persist up to 10 days" after stopping; Emsam: 2 weeks. Stacking a pharmaceutical MAOI on top of ayahuasca's MAO inhibitors and DMT. These labels also require tyramine diet restrictions for 2 weeks after stopping. Source: Nardil, Parnate (section 5.9) and Emsam labels

Bupropion (Wellbutrin SR): At least 14 days. The label's stated concern with MAOIs is "hypertensive reactions" (dangerous blood pressure spikes), not mainly serotonin. Source: Wellbutrin SR label, section 2.4

Mirtazapine (Remeron): At least 14 days. Listed by the label as an increased serotonin syndrome risk with MAOIs. Source: Remeron label, section 2.4

Trazodone (often prescribed at low dose for sleep): At least 14 days. Easy to forget because people take it "just for sleep". It is still an antidepressant with an MAOI contraindication. Source: Trazodone label, section 2.4

Lithium (lithium carbonate): No washout figure found [VERIFY]. The label warns lithium "can precipitate serotonin syndrome" and that risk rises with MAOIs; its half-life is about 18 to 36 hours. Separately, 47% of 62 online reports of lithium combined with classic psychedelics (mostly LSD and psilocybin, not ayahuasca) involved seizures (Nayak et al., 2021). ICEERS lists bipolar disorder as a psychological contraindication for ayahuasca. Source: Lithium Carbonate label, sections 5.6 and 7; Nayak et al. 2021; ICEERS 2019

St John's wort and other serotonergic products (St John's wort; also tramadol, dextromethorphan (cough syrups), triptans, tryptophan): No washout figure found [VERIFY]. The sertraline and lithium labels list St John's wort, tramadol, triptans and tryptophan as serotonergic. A 2026 case report describes severe serotonin syndrome needing intensive care after ayahuasca followed by over-the-counter dextromethorphan (Pack et al., 2026). ICEERS asks you to report all daily medication, "including herbal medicine". Source: Zoloft and Lithium labels; Pack et al. 2026; ICEERS 2019

Where the sources disagree:

  • For SSRIs other than fluoxetine, the labels say at least 14 days; Savinelli and Halpern (1995, MAPS) said 2 to 3 weeks.
  • In a randomised placebo-controlled trial of ayahuasca in people with treatment-resistant depression, researchers used a washout "adjusted to the half-life time of their current antidepressant medication", which "lasted from one to four weeks, but typically lasted two weeks" (Palhano-Fontes et al., preprint 2017). We quote this only for the washout method, not for any claim about outcomes.
  • ICEERS (2019) gives no number at all. Under "Taking ayahuasca is not recommended if..." it lists "You are taking antidepressants", and it calls ayahuasca contraindicated with "any drug or medication with an effect on the serotonin system".
  • A drug-interaction table in a 2022 hospital-pharmacy study quotes two reference databases: Lexicomp says the washout "should probably be at least 1-2 weeks" (5 weeks for fluoxetine), and Micromedex says "at least 5 weeks" after fluoxetine (Reese et al., 2022).

When does the clock actually start?

The washout starts after your last dose, which means after any taper is finished. A taper itself can take a while. The UK's NICE depression guideline (NG222, 2022) says stopping is "usually necessary" in stages, that people should talk to their prescriber first, and that withdrawal "may take weeks or months to complete successfully". It also warns that stopping abruptly or missing doses can cause withdrawal symptoms, including dizziness, "electric shock sensations", anxiety, low mood and problems sleeping.

So the real timeline is: conversation with your prescriber, then a taper they design, then the washout for your specific drug, then the retreat. If your retreat date is close, the retreat should move, not your medical plan.

There is also a bigger question underneath the numbers: whether coming off your medication is right for you at all. That is a decision for you and your prescriber. Some people stay on their medication and do not sit in ceremony, and that is a legitimate choice.

What does Taozen do?

Every person who wants to sit with us goes through the same three steps before they are accepted:

  1. A Clarity Call with our team.
  2. A health assessment reviewed by a doctor.
  3. 1:1 preparation before the retreat.

About 5% of people who do a Clarity Call are declined for a given retreat. Approval typically takes 2 to 10 days.

On medication specifically:

  • Washout length we require for each medication class: [TAOZEN POLICY: to confirm with Fred and Elisabet]
  • Who makes the final decision on medication and washout (and whether we ask for confirmation from the participant's own prescriber): [TAOZEN POLICY: to confirm with Fred and Elisabet]
  • Whether any medication or diagnosis (for example lithium, pharmaceutical MAOIs, bipolar disorder) is an automatic decline: [TAOZEN POLICY: to confirm with Fred and Elisabet]
  • Whether we require disclosure of supplements, over-the-counter medicines and recreational drugs, and over what period: [TAOZEN POLICY: to confirm with Fred and Elisabet]

If you are on any of the medications above, tell us on your Clarity Call. Leaving it out does not get you into ceremony faster. It puts you at risk.

What should you ask any retreat before you book?

Whoever you sit with, these are fair questions, and a serious team will answer them without hesitation:

  1. Who reviews my medication list, and what are their medical qualifications?
  2. What washout do you require for my specific medication, and what is that number based on?
  3. Do you want written confirmation from my prescriber that my taper is finished and when my last dose was?
  4. Do you ask about supplements, over-the-counter medicines (cough syrup, sleep aids) and recreational drugs, not only prescriptions?
  5. What happens if someone shows signs of serotonin syndrome during ceremony? Who on site can recognise it, and what is the emergency plan?
  6. Have you ever declined someone because of their medication? (If the answer is "never", ask why.)
  7. What support is there after the retreat if I am going to restart my medication?

ICEERS (2019) also suggests looking for centres where participants "go through a preliminary interview and fill a health questionnaire" and where people meeting the centre's exclusion criteria "are not allowed to drink".

Frequently asked questions

Can I drink ayahuasca while taking an SSRI?

No. The harmala alkaloids in ayahuasca block MAO, and SSRIs block serotonin reuptake. Callaway and Grob (1998) warn the combination "may induce a serotonin syndrome with potentially grave outcome", and ICEERS (2019) says taking ayahuasca is not recommended if you are taking antidepressants. Any change to your medication has to be planned with your prescriber.

How long after stopping Prozac (fluoxetine) do I need to wait?

The US Prozac label says at least 5 weeks after the last dose before starting an MAO inhibitor, because fluoxetine and its metabolite norfluoxetine clear slowly. That gap starts only after your prescriber-guided taper is finished. Whether 5 weeks is enough for ayahuasca in your case is a question for your prescriber and the retreat's medical team.

Can I just skip my antidepressant for a few days before ceremony?

No. A few days is shorter than the label washout for almost every antidepressant, and stopping suddenly can cause withdrawal symptoms such as dizziness, electric shock sensations, anxiety and low mood (NICE NG222). It can also bring back the symptoms the medication was treating. Never stop on your own. Talk to your prescriber.

I only take a low dose of trazodone for sleep. Does that count?

Yes. Trazodone is an antidepressant, and its US label says at least 14 days should pass after stopping it before starting an MAO inhibitor. Tell the retreat about it, and talk to your prescriber before changing anything.

Do herbal supplements like St John's wort count?

Yes. US drug labels for sertraline and lithium list St John's wort as a serotonergic product that raises serotonin syndrome risk. We did not find an official washout figure for it, so ask your doctor, and declare every supplement on your health assessment.

This article is general information, not medical advice. It does not replace a conversation with your own doctor or prescriber. Do not start, stop or change any medication without their guidance.

Reviewed by Elisabet, medical doctor, Taozen team. [DATE TO ADD]

Sources

  1. Callaway JC, Grob CS. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs. 1998;30(4):367-369. doi:10.1080/02791072.1998.10399712. PubMed
  2. ICEERS Foundation (Londoño D, Mazarrasa J, Aixalà MB). Towards Better Ayahuasca Practices: A Guide for Organizers and Participants. 2019. [VERIFY: link to the copy on iceers.org before publishing]
  3. ICEERS. Ayahuasca Good Practice Guide. 2014. iceers.org
  4. Halman A, Kong G, Sarris J, Perkins D. Drug-drug interactions involving classic psychedelics: a systematic review. Journal of Psychopharmacology. 2024;38(1):3-18. doi:10.1177/02698811231211219. PMC
  5. Ribeiro GSG, et al. Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. Frontiers in Molecular Biosciences. 2026;13:1768402. doi:10.3389/fmolb.2026.1768402. PubMed
  6. Pack S, Ellett TR, Pham J, Ahmad Y. Severe serotonin syndrome with acute respiratory failure following ayahuasca and dextromethorphan use: a case report. Cureus. 2026;18(8):e114211. doi:10.7759/cureus.114211. PubMed
  7. Nayak SM, et al. Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports. Pharmacopsychiatry. 2021;54(5):240-245. doi:10.1055/a-1524-2794. PubMed
  8. Palhano-Fontes F, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial. bioRxiv preprint, 2017. bioRxiv [VERIFY: cite the peer-reviewed version (Psychological Medicine, 2019) and confirm the washout wording is unchanged]
  9. Savinelli A, Halpern JH. MAOI contraindications. MAPS Newsletter. 1995;6(1). MAPS
  10. Reese T, et al. Improving the specificity of drug-drug interaction alerts: can it be done? American Journal of Health-System Pharmacy. 2022. Table 2. PMC
  11. National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222), recommendations 1.4.12 to 1.4.19 on stopping antidepressant medication. 2022. NICE
  12. US prescribing information (FDA labels) for every drug named above, via DailyMed, US National Library of Medicine, accessed 2026-10-07. [Full list of label links is in the draft file.]
Letters from the Taozen family
Fortnightly stories on preparation, integration and the Siona tradition.
Written by
Fred Billyard
Psychedelic Integration Specialist, Musician and Co Founder of Taozen
Dr. Elisabet Domínguez-Clavé
Clinical Psychologist, Researcher, Psychotherapist & Leading Ayahuasca Researcher
Meet the team